0001610717-24-000285.txt : 20240605
0001610717-24-000285.hdr.sgml : 20240605
20240605161851
ACCESSION NUMBER: 0001610717-24-000285
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240603
FILED AS OF DATE: 20240605
DATE AS OF CHANGE: 20240605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDSMITH MARK A
CENTRAL INDEX KEY: 0001246842
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39219
FILM NUMBER: 241022239
MAIL ADDRESS:
STREET 1: 925 PAGE MILL ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revolution Medicines, Inc.
CENTRAL INDEX KEY: 0001628171
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472029180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 SAGINAW DR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 415-766-3638
MAIL ADDRESS:
STREET 1: 700 SAGINAW DR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
form4.xml
X0508
4
2024-06-03
0001628171
Revolution Medicines, Inc.
RVMD
0001246842
GOLDSMITH MARK A
C/O REVOLUTION MEDICINES, INC.
700 SAGINAW DRIVE
REDWOOD CITY
CA
94063
true
true
See Remarks
true
Common Stock
2024-06-03
4
M
0
7500
4.09
A
329822
D
Common Stock
2024-06-03
4
S
0
900
39.0909
D
328922
D
Common Stock
2024-06-03
4
S
0
5699
39.9859
D
323223
D
Common Stock
2024-06-03
4
S
0
901
40.9333
D
322322
D
Common Stock
30424
I
Trust
Common Stock
30424
I
Trust
Common Stock
465604
I
Trust
Stock Option (Right to Buy)
4.09
2024-06-03
4
M
0
7500
0
D
2023-03-13
2029-03-12
Common Stock
7500
316229
D
Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 1, 2023.
Reflects the transfer of 138,057 shares previously held directly by the Reporting Person into a family trust.
Includes 232,000 restricted stock units.
This transaction was executed in multiple trades in prices ranging from $38.41 to $39.40, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
This transaction was executed in multiple trades in prices ranging from $39.41 to $40.36, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
This transaction was executed in multiple trades in prices ranging from $40.50 to $41.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Held by Jonathan Goldsmith Revocable Trust, previously Jonathan Henry Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
President and Chief Executive Officer
/s/ Jack Anders, as attorney-in fact for Mark A. Goldsmith
2024-06-05